Featured Articles

  1. The Benefits Of Transparent Pricing 6/26/2026

    Streamline biopharma budgeting and expose hidden contract manufacturing fees. An all-inclusive pricing model ensures predictable partnerships from initial scale-up to commercial approval.

  2. Addressing Regulatory Challenges For Ophthalmic Combination Products 6/17/2026

    Classifying eye drops as combination products complicates approval. Learn how identifying the primary mode of action early and aligning dual quality frameworks prevents costly launch delays.

  3. What is Hot Melt Extrusion, And How Can It Benefit Your Drug Product? 6/17/2026

    Poor API solubility delays pipelines. Discover how hot-melt extrusion creates amorphous solid dispersions to break down crystal lattices and boost bioavailability via solvent-free manufacturing.

  4. Monoclonal Vs Polyclonal Antibody Production- Explained Step By Step 6/17/2026

    Selecting the optimal antibody framework is critical. Discover how monoclonal and polyclonal epitope specificity impacts manufacturing complexity, batch uniformity, and long-term therapeutic efficacy.

  5. What To Consider When Looking For A CDMO In Drug Substance Utilization 6/17/2026

    Optimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.

  6. 3 Key Considerations When Choosing A Partner For Your Tech Transfer 6/15/2026

    One way to streamline tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum.

  7. Successful Tech Transfer Meets Commercial Needs 5/5/2026

    An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.

  8. Why The Right Partner Matters In mAb Manufacturing 3/18/2026

    Early collaboration with an expert partner streamlines HME projects through optimized formulation, strong scale‑up, solid analytics, and adaptable technologies that boost performance.

  9. Streamline HME Projects With Early Partner Engagement 3/18/2026

    Global partner delivering end‑to‑end drug development, manufacturing, and packaging with deep expertise, advanced facilities, and support across key modalities.

  10. Data-Driven Approach Optimizes Robust, Scalable Lyophilization Process

    Selecting the right manufacturing partner with appropriate lyophilization expertise, experience, and analytical capabilities can speed drug development and expedite time to market for lyophilized drugs.